MedPath

Acceptance of fibre-enriched products: Freisinger Fibre Intervention Study

Not Applicable
Conditions
metabolic syndrome
Registration Number
DRKS00013058
Lead Sponsor
ehrstuhl für Ernährungsmedizin der Technischen Universität München
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
115
Inclusion Criteria

middle aged Cohort enable central project
- 40-65 years old
- written declaration of consent
- waist circumference women > 88 cm and > men 102 cm (for the persons with metabolic risk)
- 50% men, 50% women
- Caucasian

Exclusion Criteria

- lack of declaration of consent
- current intervention study participation
- pregnancy
- current desease
- symptomatic intolerance (Gluten, Laktose, Fruktose)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary endpoint is to reduce the riskfactors for metabolic syndrome (measurements after 4 weeks and after 12 weeks intervention):<br>- Reduction of waist circumference (tape measure)<br>- Decrease of blood preasure (blood preasure monitor)<br>- Decrease of blood-triglycerol (blood sampling, laboratory test)<br>- Increase of blood HDL-Cholesterol (blood sampling, laboratory test)<br>- Decrease of blood glucoselevel (blood sampling, laboratory test)
Secondary Outcome Measures
NameTimeMethod
Secondary outcome will be measured after 4 weeks and after 12 weeks intervention:<br>- Acceptance of fiber-enriched products (questionnaires)<br>- Less energy intake by consumption of fiber-entriched products (dietary questionnaires)<br>- Changes in the microbiome (16S-sequencing)
© Copyright 2025. All Rights Reserved by MedPath